Peregrine Pharmaceuticals shares owned by Snyder Capital Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Snyder Capital Management
from 13F filings
Historical chart of Snyder Capital Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Snyder Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Snyder Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $3.8M | 311k | 12.35 |
| 2024-09-30 | $21M | 1.9M | 11.38 |
| 2024-06-30 | $14M | 2.0M | 7.14 |
| 2024-03-31 | $15M | 2.2M | 6.70 |
| 2023-09-30 | $21M | 2.2M | 9.44 |
| 2023-06-30 | $30M | 2.2M | 13.97 |
| 2023-03-31 | $32M | 1.7M | 18.76 |
| 2022-12-31 | $27M | 2.0M | 13.77 |
| 2022-09-30 | $38M | 2.0M | 19.12 |
| 2022-06-30 | $25M | 1.6M | 15.26 |
| 2022-03-31 | $34M | 1.7M | 20.37 |
| 2021-12-31 | $50M | 1.7M | 29.18 |
| 2021-09-30 | $38M | 1.8M | 21.57 |
| 2021-06-30 | $46M | 1.8M | 25.65 |
| 2021-03-31 | $40M | 2.2M | 18.23 |
| 2020-12-31 | $29M | 2.5M | 11.54 |
| 2020-09-30 | $18M | 2.3M | 7.62 |
| 2020-06-30 | $15M | 2.3M | 6.57 |
| 2020-03-31 | $12M | 2.3M | 5.11 |
| 2019-12-31 | $17M | 2.2M | 7.67 |
| 2019-09-30 | $12M | 2.3M | 5.30 |
| 2019-06-30 | $13M | 2.2M | 5.60 |
| 2019-03-31 | $10M | 2.4M | 4.25 |
| 2018-12-31 | $8.6M | 2.1M | 4.10 |
| 2018-09-30 | $13M | 1.9M | 6.86 |